BBA
CBST

Baker Bros. Advisors’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Baker Bros. Advisors’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,000
Closed -$318K – 100
2013
Q3 		$318K Hold
5,000
– – ﹤0.01% 80
2013
Q2 		$241K Buy
+5,000
New +$246K ﹤0.01% 73

Other funds holding CBST

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Baker Bros. Advisors's CBST Position: Q4 2013 in Review

Baker Bros. Advisors sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2013, closing a stake of 5,000 shares — an estimated $318K sold.

Baker Bros. Advisors first reported a position in CBST in Q2 2013 and held it in 2 quarters. The position peaked at $318K in Q3 2013. 276 funds tracked by Wall St. Rank hold CBST as of Q4 2013.

  • Baker Bros. Advisors reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Baker Bros. Advisors sold 5,000 CUBIST PHARMACEUTICALS INC shares in Q4 2013, an estimated $318K.
  • Baker Bros. Advisors first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Baker Bros. Advisors's CUBIST PHARMACEUTICALS INC position peaked at $318K in Q3 2013.
  • 276 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2013.

Based on Baker Bros. Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.